Milestone Pharmaceuticals Inc. (MIST) vs Polaryx Therapeutics, Inc. Common Stock (PLYX)

A side-by-side comparison of Milestone Pharmaceuticals Inc. and Polaryx Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Milestone Pharmaceuticals Inc. logo
MIST
Milestone Pharmaceuticals Inc.
$97M
$0.78HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT
Polaryx Therapeutics, Inc. Common Stock logo
PLYX
Polaryx Therapeutics, Inc. Common Stock
$104M
$2.08HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT

Total return — MIST vs PLYX

growth of $100 · dividends reinvested · last 1y
MIST -60.2% (-60.2%/yr)PLYX -94.1% (-94.1%/yr)MIST compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100$40$6
MIST PLYX

MIST vs PLYX: by the numbers

  • •PLYX is the larger company ($104M vs $97M market cap).
  • •Both run net losses; PLYX's is the smaller (0.00% vs -3585.62% net margin).

Metrics side by side

Valuation

MetricMISTPLYX
P/S ratio41.57N/A
P/B ratio5.359.48

Profitability

MetricMISTPLYX
Gross margin94.58%0.00%
Operating margin-4041.72%0.00%
Net margin-3585.62%0.00%
ROE-461.14%-62.61%
ROIC-49.27%-47.75%

Growth (annualized)

MetricMISTPLYX
Revenue CAGR (5Y)-31.02%N/A
Total return CAGR (5Y)-33.18%N/A

Go deeper

Full MIST analysisFull PLYX analysisInteractive comparison tool

Dig into the metrics

Milestone Pharmaceuticals ROEPolaryx Therapeutics, Inc. Common Stock ROEMilestone Pharmaceuticals operating marginPolaryx Therapeutics, Inc. Common Stock operating marginMilestone Pharmaceuticals revenue growthPolaryx Therapeutics, Inc. Common Stock revenue growthMilestone Pharmaceuticals free cash flowPolaryx Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.